Lloyd Inc. Recalls Thyro-Tab 0.300 mg Tablets Due to cGMP Deviations
Lloyd Inc. of Iowa is recalling 1,902,957 Thyro-Tab 0.300 mg tablets because they do not meet in-process specification requirements.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a manufacturing deviation (cGMP) without reported harm, fitting the Moderate category for low-risk contamination or voluntary precautionary recalls.
Plain-English summary
Lloyd Inc. of Iowa is recalling 1,902,957 tablets of Thyro-Tab 0.300 mg. The product is packaged in 150,000-tablet bulk drums for repackaging and is a prescription (RX) medication. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
The recall was initiated because the product does not meet in-process specification requirements and involves cGMP (Current Good Manufacturing Practice) deviations. The specific nature of the deviations is not detailed in the source text.
Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution. The affected lot number is HE35311. Consumers and healthcare providers should check their inventory for this specific lot and contact their healthcare provider or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- Thyro-Tab 0.300 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Thyroid Medication
- Affected units
- 1,902,957
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #HE35311
Distribution
Part of a larger recall action
This product is one of 12 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 12 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14